Anxiety disorders: Assessment and management in general practice

Australian Family Physician

Volumn 40, Issue 6, 2011, Pages 370-374

  Kyrios, Michael ^a   Moulding, Richard ^a   Nedeljkovic, Maja ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Anxiety disorders; Mental health; Treatment

Indexed keywords

ANXIETY DISORDER; ARTICLE; COMORBIDITY; GENERAL PRACTICE; HUMAN;

ANXIETY DISORDERS; COMORBIDITY; GENERAL PRACTICE; HUMANS;

EID: 79959557439     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Teesson M, Slade T, Mills K. Comorbidity in Australia, findings of the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2009, 3, 606-14.
2. Australian Bureau of Statistics. Survey of Mental Health and Wellbeing, summary of results. Publication 4326.0, 2007.
3. Fredrikson M, Annas P, Fischer H, Wik G. Gender and age differences in the prevalence of specific fears and phobias. Behav Res Ther 1996, 34, 33-9.
4. Burgess PM, Pirkis JE, Slade TN, Johnston AK, Meadows GN, Gunn JM. Service use for mental health problems, findings from the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2009, 43, 615-23.
5. Harrison C, Britt H. The rates and management of psychological problems in Australian general practice. Aust N Z J Psychiatry 2004, 38, 781-8.
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edn. Washington, DC, American Psychiatric Association, 2000.
7. Andrews G, Slade T, Issakidis C. Deconstructing current comorbidity, data from the Australian National Study of Mental Health and Well-Being. Br J Psychiatry 2002, 181, 306-14.
8. Issakidis C, Andrews G. Service utilisation for anxiety in an Australian community sample. Soc Psychiatry Psychiatr Epidemiol 2002, 37, 153-63.
9. Salkovskis PM, Warwick HMC, Deale AC. Cognitive-behavioral treatment for severe and persistent health anxiety (hypochondriasis). Brief Treat Crisis nterv 2003, 3, 353-68.
10. Lovibond PF, Lovibond SH. The structure of negative emotional states, comparison of the Depression Anxiety Stress Scales with the Beck Depression and Anxiety Inventories. Behav Res Ther 1995, 33, 335-43.
11. Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 1990, 28, 487-95.
12. Kyrios M, Hegarty K. Self-monitoring and psychometric tools. In, Blashki G, Judd F, Piterman L, editors. General practice psychiatry. North Ryde, NSW, McGraw-Hill, 2007, 356-72.
13. Olatunji BO, Cisler JM, Deacon BJ. Efficacy of cognitive behavioral therapy for anxiety disorders, a review of meta-analytic findings. Psychiatr Clin North Am 2010, 33, 557-77.
14. Deacon BJ, Abramowitz JS. Cognitive and behavioral treatments for anxiety disorders, a review of meta-analytic findings. J Clin Psychol 2004, 60, 429-41.
15. Allen NB, Chambers R, Knight W. Melbourne Academic Mindfulness Interest Group. Mindfulness-based psychotherapies, a review of conceptual foundations, empirical evidence and practical considerations. Aust N Z J Psychiatry 2006, 40, 285-94.
16. Roemer L, Orsillo SM, Salters-Pedneault K. Efficacy of an acceptance-based behavior therapy for generalized anxiety disorder, evaluation in a randomized controlled trial. J Consult Clin Psychol 2008, 76, 1083-9.
17. Kyrios M. Exposure and response prevention in the treatment of obsessivecompulsive disorder. In, Menzies R, Silva P de, editors. Obsessive-compulsive disorder, theory, research and treatment. Chichester, England, Wiley, 2003, 259-74.
18. Kazantzis N, Deane FP, Ronan KP. Homework assignments in cognitive and behavioral therapy, a meta-analysis. Clin Psychol 2000, 7, 189-202.
19. Ravindran LN, Stein MB. The pharmacologic treatment of anxiety disorders, a review of progress. J Clin Psychiatry 2010, 71, 839-54.
20. Lader MH. Limitations on the use of benzodiazepines in anxiety and insomnia, are they justified? Eur Neuropsychopharmacol 1999, 9, S399-405.
21. Kaplan EM, Du Pont RL. Benzodiazepines and anxiety disorders, a review for the practicing physician. Curr Med Res Opin 2005, 21, 941-50.
22. Cloos JM, Ferreira V. Current use of benzodiazepines in anxiety disorders. Curr Opin Psychiatry 2009, 22, 90-5.
23. Chessick CA, Allen MH, Thase M, et al. Azapirones for generalized anxiety disorder. Cochrane Database Syst Rev, Issue 3. Art. No., CD006115. DOI, 10.1002/14651858.CD006115. 2006.
24. Foa EB, Franklin ME, Moser J. Context in the clinic, How well do cognitivebehavioral therapies and medications work in combination? Biol Psychiatry 2002, 52, 987-97.
25. Hofmann SG, Sawyer AT, Korte KJ. Is it beneficial to add pharmacotherapy to cognitive-behavioral therapy when treating anxiety disorders? A metaanalytic review. Int J Cogn Ther 2009, 2, 160-75.
26. Otto MW, McHugh RK, Kantak KM. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders, medication effects, glucocorticoids, and attenuated treatment outcomes. Clin Psychol Sci Pract 2010, 17, 91-103.
27. Jorm AF, Korten AE, Rodgers B, et al. Belief systems of the general public concerning the appropriate treatments for mental disorders. Soc Psychiatry Psychiatric Epidemiol 1997, 32, 468-73.
28. Deacon BJ, Abramowitz JS. Patients perceptions of pharmacological and cognitive-behavioral treatments for anxiety disorders. Behav Ther 2005, 36, 139-5.